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Intrathecal antibody synthesis is a well-documented phe-
nomenon in infectious neurological diseases as well as in
demyelinating diseases. Intrathecal antibody synthesis
against HTLV-1 has been reported in HAM/TSP, but
little is known about the role of B cells and humoral
immune responses in the central nervous systems (CNS)
of HAM/TSP patients. Here we demonstrate profiles of
HTLV-1-specific antibodies in cerebrospinal fluid (CSF)
of HAM/TSP patients. Of 36 HAM/TSP patients, anti-
body responses against Gag and Tax were detected in
CSF of all the patients. CSF/Serum antibody ratio was
elevated in anti-Gag (mean 1.20) more than in anti-Tax
(mean 0.85), but importantly HAM/TSP patients with
lesions or atrophy in spinal cord showed higher CSF/
Serum anti-Gag antibody ratio. Antibody response against
Env was detected in CSF of 94.4% of patients, but CSF/
serum anti-Env ratio was significantly lower than those of
anti-Gag and anti-Tax (mean 0.18). 19 patients were
further studied for oligoclonal band (OCB) specificity to
HTLV-1 antigens and all of them were found to have
bands specific for at least one antigen studied. Signifi-
cantly higher proportion of patients had Gag- or Env-
specific OCBs than Tax-specific OCBs. Interestingly,
CXCL13 (B cell attracting chemokine-1) was increased in
CSF of HAM/TSP patients, which was associated with
higher HTLV-1-specific antibody responses in CSF and
was correlated with decrease of plasma blasts in periph-
eral blood. These results highlight the importance of the
B cell compartment in HAM/TSP where production of
HTLV-1-specific antibody may be required to control
viral persistence and/or may be associated with HAM/
TSP disease progression.
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